JANINE PRIME: Open Payments
NPI 1669996062 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 63 payments from 15 companies in 2025. Trend: 2023 $465 · 2024 $1,557 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $305 |
| Novo Nordisk Inc | 12 | $260 |
| Amgen Inc. | 9 | $160 |
| Lilly USA, LLC | 6 | $129 |
| ABBVIE INC. | 4 | $85 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| Bausch Health US, LLC | 3 | $63 |
| Astellas Pharma US Inc | 3 | $59 |
| Exact Sciences Corporation | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
Products named: NURTEC ODT, OTEZLA, Wegovy, PREVNAR 20, MOUNJARO, Rybelsus, JARDIANCE, APLENZIN.
Industry payments across VA — which companies pay providers there.
